Cytostatic product(s) released by activated macrophages, unrelated to interleukin 1, tumor necrosis factor alpha, and

M Lepoivre1, H Boudbid, G Lemaire

  • 1U.A. CNRS 1116, Institut de Biochimie, Université de Paris-Sud, Orsay, France.

Cellular Immunology
|September 1, 1988
PubMed

Insights

Activated macrophages release cytostatic factors that inhibit DNA synthesis in EMT6 cells. These factors, with a molecular weight over 10,000 Da, are protein-based and distinct from common cytokines like IL-1, TNF-alpha, and IFN-alpha/beta.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Murine peritoneal macrophages can be activated for cytotoxic functions.
  • Activated macrophages release soluble factors that can affect target cell proliferation.

Purpose of the Study:

  • To characterize the cytostatic factor(s) released by activated macrophages.
  • To determine the nature and specificity of the anti-proliferative activity.

Main Methods:

  • Macrophage activation in vivo (trehalose dimycolate) and in vitro (lipopolysaccharide).
  • Collection and ultrafiltration of conditioned media (CM).
  • Assays for DNA synthesis inhibition in target cell lines (EMT6, P815, R-L929, KB, HT29).
  • Protease sensitivity assays and characterization of inhibitory substances.

Main Results:

  • Activated macrophages released cytostatic factor(s) in CM that completely blocked EMT6 cell DNA synthesis within 16 hours.
  • The cytostatic activity was specific, with EMT6 cells being highly sensitive, while P815 and R-L929 were less sensitive, and KB and HT29 were resistant.
  • The active factor(s) had a molecular weight greater than 10,000 Da, were destroyed by proteases, and were inhibited by products from P815 cells.
  • No correlation was found with Interleukin-1 (IL-1), Tumor Necrosis Factor alpha (TNF-alpha), or Interferon-alpha/beta (IFN-alpha/beta), as these cytokines showed minimal or no cytostatic effect on EMT6 cells.

Conclusions:

  • Activated macrophages produce potent, proteinaceous cytostatic factor(s) that selectively inhibit DNA synthesis in specific target cells.
  • The identified cytostatic activity is distinct from commonly studied cytokines like IL-1, TNF-alpha, and IFN-alpha/beta.
  • Further research is needed to identify the precise molecular nature of these novel cytostatic factors.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...